|
|
|
| |
News - St John Regional Hospital, Saint John New Brunswick Canada |
|
|
|
|
|
|
| St John Regional Hospital |
| First patients in Germany treated with Delcath Hepatic CHEMOSAT Delivery System |
| Date : - 27/03/2012 |
|
Delcath Systems, Inc., (NASDAQ: DCTH) announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.
Two patients were treated for inoperable, liver-dominant metastases, one from cutaneous melanoma and one from breast cancer. The treating physicians reported that both patients were treated successfully without procedure-related complications.
Dr. Thomas J. Vogl, Director of the Institute for Diagnostic and Interventional Radiology at J.W. Goethe, said, "We believe this technology has significant potential to help control cancers in the liver. We're pleased to be the first cancer center to begin offering this important treatment option to patients in Germany, and are eager to further explore its role in the treatment of multiple tumor types including breast cancer."
"Delcath's partnership with J.W. Goethe reinforces the potential of CHEMOSAT," said Eamonn P. Hobbs, president and CEO of Delcath. "We recently treated our first patients in Milan and are eager to continue our expansion across Europe. Opening another CHEMOSAT treatment center and treating patients in the continent's largest market is another step forward in the commercialization of this technology." |
|
| Reference : - www.news-medical.net/news/20120227/First-patients-in-Germany-treated-with-Delcath-Hepatic-CHE |
| Back To List |
|
|
|
|
|
| Copyright © 2024 Medical Tour Information All Rights Reserved |
|